Horizon Lines Inc
Purchase-Price Allocation
Goodwill
$221.8M
Matson, Inc. — Key Metrics
3 years of history · ending 2025-12-31 · SEC EDGAR
Forensics
Three classic accounting-quality scores. F-Score (0-9, higher = better fundamentals); M-Score (>-1.78 flags possible manipulation); Z-Score (>2.99 = safe, <1.81 = distressed). Use together — single-score readings are noisy.
F-Score (Piotroski 0-9)
Per Share Metrics
Expense Ratios
Working Capital Analysis
Valuation Multiples
Cash-Flow Multiples
Enterprise Value Multiples
52-Week Range
Trailing Returns
ROIC vs WACC
Yields
Capital Deployment Yields
Liquidity & Leverage Ratios
Earnings Quality (OCF/NI · FCF/NI · Sloan Accruals)
EPS (Diluted)
$14
Book Value Per Share
$86
Free Cash Flow Per Share
$5
Cash Per Share
$4
Revenue Per Share
$104
OCF Per Share
$17
Return on Equity
16.4%
Return on Assets
9.6%
Return on Invested Capital
13.7%
Debt to Equity
0.11
Current Ratio
0.89
Quick Ratio
0.89
Asset Turnover
0.72
Days Payables Outstanding
—
Days Inventory On Hand
—
SBC / Revenue
0.7%
Capex / Revenue
11.8%
Working Capital
$-56M
Net Current Asset Value
$472M
Invested Capital
$3.07B
OCF / Net Income
1.23
FCF / Net Income
0.35
Accruals Ratio (Sloan)
-2.2%
Net Debt
$210M
Net Debt / EBITDA
0.32
Interest Coverage
73.50
Cash Coverage
80.46
Dividend Coverage
12.18
Capex Coverage
1.39
Tangible Common Equity
$2.28B
TCE / Total Assets
49.3%
Goodwill / Total Assets
7.1%
NOPAT
$416M
Cash ROIC
5.1%
WC / Revenue
-1.7%
Capex / D&A
2.67
Reinvestment Rate
49.2%
Total Payout Ratio
78.3%
Asset Growth vs Revenue Growth
3.1%
Revenue 5Y CAGR
7.0%
EPS 5Y CAGR
18.2%
FCF 5Y CAGR
-18.6%
EBITDA 5Y CAGR
11.4%
Book Value 5Y CAGR
23.5%
Stock Price (FY-end)
$123
Market Cap
$3.97B
P/E Ratio
8.92
P/S Ratio
1.19
P/B Ratio
1.44
P/TB Ratio
1.74
P/OCF Ratio
7.26
P/FCF Ratio
25.83
Enterprise Value
$4.18B
EV / EBITDA
6.46
EV / Sales
1.25
EV / FCF
27.19
FCF Yield
3.9%
Dividend Yield
1.1%
Shareholder Yield
8.2%
Buyback Yield
7.6%
Capex Yield
9.9%
Dividend Per Share
$1
DPS YoY Growth
6.4%
Operating Leverage
4.14
Graham Number
$163
Shares Variation (YoY)
-5.8%
Beta (5Y)
1.11
Cost of Equity
10.1%
Cost of Debt (after tax)
1.6%
WACC
9.4%
ROIC - WACC Spread
4.3%
52W High
$147
52W Low
$88
Trailing Return 1Y
-8.4%
Trailing Return 5Y
132.2%
F-Score (Piotroski)
5.00
Earnings Forecasts
Per-quarter consensus estimates + actuals + beat/miss surprise. Sourced from Finnhub (Wall Street consensus aggregation).
Source caveat: Finnhub free tier returns the consensus mean only — analyst high / low / dispersion + analyst counts require a paid plan. A "$5.00 consensus" line above could mean "20 analysts at exactly $5" (high conviction) or "10 at $5.50, 10 at $4.50" (split). Treat single-line consensus accordingly.
EPS — Consensus vs Actual
Revenue — Consensus vs Actual
Beat / Miss vs Estimate
Stock Price on Earnings Dates
Matson, Inc. — Effective Tax Rate ReconciliationNEW
Bridges from the federal statutory rate (21% post-TCJA) to the effective tax rate via the issuer's tax-note reconciliation lines. Sourced from EffectiveIncomeTaxRateReconciliation* flat CompanyFacts concepts. Conditional lines (R&D credits, FDII, SBC, valuation allowance, etc.) only render when the issuer discloses them. Persistent divergence between accrual tax expense and cash taxes paid is a leading signal for deferred-tax buildup.
Effective Rate Trend
| Reconciliation Line | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Federal Statutory Rate | 21.00% | 21.00% | 21.00% | 21.00% | 21.00% | 21.00% |
| State & Local Income Taxes | 3.50% | 3.10% | 2.80% | 1.20% | 2.20% | -1.60% |
| Foreign Rate Differential | 0.60% | 0.20% | 0.10% | 0.70% | 0.30% | 0.50% |
| Other Adjustments | 1.00% | -0.30% | -0.30% | 0.60% | — | -0.50% |
| FDII Deduction | — | 2.50% | 2.40% | 4.80% | 3.10% | 2.50% |
| SBC (Nondeductible) | -0.50% | -0.20% | — | 0.50% | 0.20% | 0.30% |
| Nondeductible Expenses | — | — | — | — | — | — |
| Valuation Allowance Change | — | — | — | — | — | — |
| Effective Tax Rate | 25.40% | 20.80% | 21.30% | 20.30% | 20.50% | 16.70% |
Cash vs Accrual
| Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Income Tax Expense (Accrual) | $65.9M | $243.9M | $288.4M | $75.9M | $123.0M | $89.0M |
| Income Taxes Paid (Cash) | −$16.1M | $241.6M | $215.2M | $7.5M | −$26.5M | $86.1M |
Matson, Inc. — M&A AcquisitionsNEW
Per-deal acquisition disclosures sourced from us-gaap:BusinessAcquisitionAxis dimensional XBRL. Each card surfaces the deal's purchase-price allocation (goodwill vs intangibles vs liabilities), contingent consideration (unpaid earn-outs), and pro-forma combined-entity numbers. Probability-of-Success (PoS) factor on biotech targets is the ASC 805 contingent-consideration valuation — higher = closer to commercialization, higher implied target value.
Span Alaska
Purchase-Price Allocation
Goodwill
$78.6M
Series Of Individually Immaterial Business Acquisitions
Purchase-Price Allocation
Goodwill
$26.6M
Matson, Inc. — Litigation CasesNEW
Per-case litigation disclosures sourced from us-gaap:LossContingenciesByNatureOfContingencyAxis dimensional XBRL. Coverage is sparse — most filers aggregate at the parent level (JNJ talc, PFE opioid) — but high-value when per-case disclosure exists. Loss estimate is either a single point or a low/high range, depending on how the issuer values the contingency.
As of 2025-12-31
| Case | Estimated Loss | Damages Sought | Settlement |
|---|---|---|---|
| Surety Bond | $84M | — | — |